QMENTA has amassed the most advanced and widely used imaging biomarkers on its platform to enable experts to measure the efficacy of treatments under trial or research in a single environment.
Multiple Sclerosis
State-of-the-art biomarkers for lesion count, activity, load, diffusion, and volume
Alzheimer’s Disease
Advanced biomarkers for volumetry and connectivity
Parkinson’s Disease
Advanced biomarkers for volumetry and thickness
Brain Oncology
State-of-the-art biomarkers for contrast, perfusion, tumor volume, and Gadolinium
Neuropsychiatric Diseases
Advanced biomarkers for connectivity, volume, and thickness
